Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility

▤ Summary

Idorsia closed a senior secured term loan agreement with Pharmakon Advisors worth up to CHF 250 million. The company received an initial CHF 150 million tranche at closing and used part of it to fully repay its CHF 105 million New Money Facility, including OID and interest. The refinancing removes near-term maturities and improves Idorsia’s balance sheet and liquidity. This is a financing and capital-structure event for a commercial-stage life sciences company, not a software product or staffing announcement.

▦ Linked Companies